Benzinga - Fri, 22 Jan 2021 05:54:13 -0400
Benzinga - Thu, 21 Jan 2021 13:01:09 -0400
Benzinga - Tue, 19 Jan 2021 13:49:05 -0400
Benzinga - Wed, 13 Jan 2021 17:57:28 -0400
Benzinga - Wed, 13 Jan 2021 16:59:37 -0400
Benzinga - Thu, 05 Nov 2020 09:47:00 -0400
Benzinga - Tue, 29 Sep 2020 09:01:19 -0400
Benzinga - Tue, 29 Sep 2020 07:47:04 -0400
Benzinga - Tue, 29 Sep 2020 06:32:09 -0400
Benzinga - Thu, 20 Aug 2020 07:36:04 -0400
Benzinga - Fri, 07 Aug 2020 07:42:38 -0400
Benzinga - Tue, 14 Jul 2020 07:04:15 -0400
Benzinga - Mon, 29 Jun 2020 08:19:06 -0400
Benzinga - Mon, 22 Jun 2020 08:17:25 -0400
Benzinga - Wed, 10 Jun 2020 09:16:04 -0400
load more
Sector: Health Care.Industry: Biotechnology
Orgenesis Inc is a part of the healthcare sector. It is a fully-integrated biopharmaceutical company focused on developing trans-differentiation technologies for diabetes and vertically integrating manufacturing that can optimize its abilities to scale-up its technologies for clinical trials and eventual commercialization. The group operates in two segments namely CDMO and POC. The company is also engaged in applying its disciplined execution to emerging technologies of other cell therapy markets in such areas as cell-based cancer immunotherapies and neurodegenerative diseases.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-05-10
REV
Q4 2020Est.ActualSurprise
EPS
(EXPECTED)2021-03-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
ORGSOrgenesis-2.96%166.4M

Orgenesis Company Questions & Answers

Q

How do I buy Orgenesis (ORGS) stock?

A

You can purchase shares of Orgenesis (NASDAQ: ORGS) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Orgenesis's (ORGS) main competitors?

A

Other companies in Orgenesis’s space includes: DiaMedica Therapeutics (NASDAQ:DMAC), GlycoMimetics (NASDAQ:GLYC) and CollPlant Biotechnologies (NASDAQ:CLGN).

Q

What is the target price for Orgenesis?

A

The latest price target for Orgenesis (NASDAQ: ORGS) was reported by Benchmark on 2019-09-26. The analyst firm set a price target for 9.00 expecting ORGS to rise to within 12 months (a possible 30.62% upside). 0 analyst firms have reported ratings in the last year.

Q

How much is Orgenesis (ORGS) stock ?

A

The stock price for Orgenesis (NASDAQ: ORGS) is $6.89 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).

Q

When is the next Orgenesis (ORGS) dividend?

A

There are no upcoming dividends for Orgenesis.

Q

When is Orgenesis (NASDAQ:ORGS) reporting earnings?

A
Orgenesis’s Q1 earnings are confirmed from now on May 10, 2021.
Q

When is the upcoming split for ORGS?

A

There is no upcoming split for Orgenesis.